Mélanie Thill-Tayara

Dechert LLP

Articles

Results 1 to 5 of 20
Most popular |Most recent


Global overview

Global - December 6 2019 For several years now, the pharmaceutical industry has stood out as being under the increased scrutiny of competition authorities worldwide. This new...

Anticompetitive agreements in the pharmaceutical sector in European Union

European Union - September 6 2019 An overview of essential considerations surrounding anticompetitive agreements in the pharmaceutical sector in European Union, including the assessment framework and special issues with vertical agreements....

Marion Provost.

Pharmaceutical antitrust law in European Union

European Union - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in European Union, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance....

Marion Provost.

Anticompetitive unilateral conduct in the pharmaceutical sector in European Union

European Union - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in European Union, including IP rights abuse and pricing conduct....

Marion Provost.

Remedies in private antitrust litigation in France

France - August 22 2019 An overview of available remedies and related considerations in private antitrust litigation in France, including compensation, interim remedies, legal costs and defences....

Marion Provost.